Skip to main content
FinSpry Logo
FinSpry
A
ALMR
(NASDAQ)
Alamar Biosciences, Inc.
$20.51-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Alamar Biosciences (ALMR) Income Statement

Revenue, expenses, profit margins, and earnings with annual and quarterly data.

Alamar Biosciences Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Income StatementBalance SheetCash FlowRatios
Scroll to see more
Alamar Biosciences, Inc. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024
Period EndingDec 2025Dec 2024
Revenue & Gross Profit
Revenue74.2125.14
Cost of Revenue32.5116.54
Gross Profit41.718.61
Operating Expenses
Research & Development37.4739.23
Selling, General & Administrative35.5718.94
Operating Expenses73.0458.18
Operating Income-31.33-49.57
Other Income/Expense
Interest Income2.164.68
Interest Expense-0.40-2.08
Other Income/Expense0.42-0.09
Income
Income Before Tax-29.15-47.06
Income Tax Expense0.670.01
Net Income-29.82-47.07
Net Income - Continuous Operations-29.82-47.07
Net Income - Discontinued Operations0.000.00
EBITDA-28.57-47.27
EBIT-31.33-49.57
Depreciation & Amortization2.762.29
Earnings Per Share
Basic EPS-1.00-2.00
Diluted EPS-1.00-2.00
Basic Shares Outstanding27.9225.44
Diluted Shares Outstanding27.9228.75

Metrics Derived from the Income Statement

These financial metrics are calculated using income statement data. Learn how each metric works and screen stocks by them.

Revenue

Total sales generated from business operations

Earnings Per Share (EPS)

Net income allocated to each outstanding share

Gross Margin

Revenue remaining after cost of goods sold

Operating (EBIT) Margin

Profitability from core operations before interest and taxes

Net Profit Margin

Percentage of revenue retained as profit after all expenses

EBITDA

Earnings before interest, taxes, depreciation, and amortization

View Alamar Biosciences Ratios →Screen Stocks by Profitability →